Cancer Research UK logo.
SearchDonate
  • Search

A trial of ibrutinib with rituximab and either CHOP or bendamustine for low grade non Hodgkin lymphoma (SELENE)

Overview

Cancer types:

Blood cancers, Cell type, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at a drug called ibrutinib alongside chemotherapy and rituximab for low grade lymphoma that has got worse or come back despite having other treatment.

Certain types of non Hodgkin lymphoma are slow growing. They are called low grade or indolent lymphoma.

Recruitment start: 24 March 2014

Recruitment end: 31 October 2015

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Simon Rule

Supported by

Janssen-Cilag

NIHR Clinical Research Network: Cancer

Last reviewed: 12 November 2015

CRUK internal database number: 11349

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.